otal Antioxidant Capacity (TAC), a biomarker measuring the antioxidant potential of body fluids, including redox synergistic interactions, is influenced by the presence of products of catabolism such as bilirubin (BR) and uric acid (UA). Hyperuricaemia and increased BR levels were observed in thalassemia. In order to evaluate the differences in TAC values between thalassemic patients and healthy subjects, we performed a systematic review and meta-analysis of case-control studies. After the exclusion of data deemed unsuitable for meta-analysis inclusion and a study imputed of bias by Trim-and-fill analysis, mean difference (MD) and confidence intervals 95% (CI 95%) were calculated by the random effect model for beta-thalassemia major (BTM) (1351 subjects: 770 thalassemic and 581 controls, from 15 studies) and Trait (BTT) or Hemoglobin E (BTE) (475 subjects: 165 thalassemic and 310 controls, from 5 studies). Despite the differences in clinical symptoms and severity, similar decreased levels of TAC were found in BTM [MD -0.22 (-0.35 -0.09) p < 0.001] and BTT or BTE [MD -0.22 (-0.44 -0.01) p < 0.05]. In conclusion, UA and BR interference on TAC suggests that corrected TAC and in particular the UA-independent TAC, considering the prominent influence of UA, might be the better approach to evaluate body antioxidant status. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

Total antioxidant capacity in beta-thalassemia: a systematic review and meta-analysis of case-control studies / Manafikhi, Husseen; Drummen, Gregor; Palmery, Maura; Peluso, Ilaria. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - ELETTRONICO. - 110:(2017), pp. 35-42. [10.1016/j.critrevonc.2016.12.007]

Total antioxidant capacity in beta-thalassemia: a systematic review and meta-analysis of case-control studies

MANAFIKHI, HUSSEEN;PALMERY, Maura;PELUSO, Ilaria
2017

Abstract

otal Antioxidant Capacity (TAC), a biomarker measuring the antioxidant potential of body fluids, including redox synergistic interactions, is influenced by the presence of products of catabolism such as bilirubin (BR) and uric acid (UA). Hyperuricaemia and increased BR levels were observed in thalassemia. In order to evaluate the differences in TAC values between thalassemic patients and healthy subjects, we performed a systematic review and meta-analysis of case-control studies. After the exclusion of data deemed unsuitable for meta-analysis inclusion and a study imputed of bias by Trim-and-fill analysis, mean difference (MD) and confidence intervals 95% (CI 95%) were calculated by the random effect model for beta-thalassemia major (BTM) (1351 subjects: 770 thalassemic and 581 controls, from 15 studies) and Trait (BTT) or Hemoglobin E (BTE) (475 subjects: 165 thalassemic and 310 controls, from 5 studies). Despite the differences in clinical symptoms and severity, similar decreased levels of TAC were found in BTM [MD -0.22 (-0.35 -0.09) p < 0.001] and BTT or BTE [MD -0.22 (-0.44 -0.01) p < 0.05]. In conclusion, UA and BR interference on TAC suggests that corrected TAC and in particular the UA-independent TAC, considering the prominent influence of UA, might be the better approach to evaluate body antioxidant status. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
2017
beta-thalassemia; bilirubin; meta-analysis; total antioxidant capacity; uric acid
01 Pubblicazione su rivista::01a Articolo in rivista
Total antioxidant capacity in beta-thalassemia: a systematic review and meta-analysis of case-control studies / Manafikhi, Husseen; Drummen, Gregor; Palmery, Maura; Peluso, Ilaria. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - ELETTRONICO. - 110:(2017), pp. 35-42. [10.1016/j.critrevonc.2016.12.007]
File allegati a questo prodotto
File Dimensione Formato  
Manafikhi_postprint_Total-antioxidant_2017.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 514.4 kB
Formato Adobe PDF
514.4 kB Adobe PDF
Manafikhi_Total-antioxidant_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 998.01 kB
Formato Adobe PDF
998.01 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/916268
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 19
social impact